Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Argiris, Athanassios
Item TypeName
Concept Antineoplastic Agents
Concept Antineoplastic Agents, Phytogenic
Concept Antineoplastic Agents, Hormonal
Academic Article Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
Academic Article Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Academic Article A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Academic Article Targeting growth factors and angiogenesis; using small molecules in malignancy.
Academic Article Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Academic Article A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer.
Academic Article Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
Academic Article A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
Academic Article Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies.
Academic Article Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas.
Academic Article Update on the role of EGFR inhibitors in cancer therapeutics.
Academic Article Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab.
Academic Article XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.
Academic Article Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer.
Academic Article Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.
Academic Article Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.
Academic Article Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
Academic Article Synergistic interactions between tamoxifen and trastuzumab (Herceptin).
Academic Article Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Academic Article Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
Academic Article Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
Academic Article Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.
Academic Article p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.
Academic Article Growth and molecular interactions between tamoxifen and trastuzumab.
Academic Article Induction chemotherapy for head and neck cancer: will history repeat itself?
Academic Article Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer.
Academic Article Pemetrexed in head and neck cancer: a systematic review.
Search Criteria
  • Antineoplastic Agents